Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for thyroid disease in pregnancy.

J H Lazarus1, L D K E Premawardhana

  • 1Centre for Endocrine and Diabetes Sciences, Cardiff University, Cardiff CF14 4XN, Wales, UK. Lazarus@cf.ac.uk

Journal of Clinical Pathology
|April 29, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monitoring iodine nutritional status: adults or schoolchildren?

Journal of endocrinological investigation·2020
Same author

HYPOTHYROXINAEMIA AND BRAIN DEVELOPMENT.

Acta endocrinologica (Bucharest, Romania : 2005)·2019
Same author

Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement.

Orphanet journal of rare diseases·2017
Same author

Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit.

Orbit (Amsterdam, Netherlands)·2017
Same author

Current challenges in the pharmacological management of thyroid dysfunction in pregnancy.

Expert review of clinical pharmacology·2016
Same author

Update on a new controversy in endocrinology: isolated maternal hypothyroxinemia.

Journal of endocrinological investigation·2014

Screening pregnant women for thyroid dysfunction is recommended due to risks of hypothyroidism impacting child development and maternal health. Early detection and treatment, alongside optimized iodine intake, are crucial for better outcomes.

Area of Science:

  • Endocrinology
  • Obstetrics
  • Neonatal Development

Background:

  • Hypothyroidism affects 2.5% of pregnant women, linked to adverse neonatal and maternal outcomes.
  • Postpartum thyroid dysfunction (PPTD) occurs in 5-9% of women, predicted by antithyroid peroxidase antibodies (antiTPOAb).
  • Gestational hyperthyroidism is rare (0.2%), but hypothyroidism poses significant risks.

Purpose of the Study:

  • To evaluate the importance of screening for thyroid dysfunction during pregnancy.
  • To highlight the role of thyroid hormones (T4) and iodine in fetal neurodevelopment.
  • To discuss strategies for managing and predicting thyroid dysfunction in pregnancy.

Main Methods:

  • Review of existing data on thyroid dysfunction prevalence and risks in pregnancy.

Related Experiment Videos

  • Discussion of screening methods including T4 and thyroid-stimulating hormone (TSH) measurements.
  • Consideration of iodine intake recommendations (200 microg/day) and antiTPOAb measurement for PPTD prediction.

    • Main Results:

    • Hypothyroidism is associated with impaired neuropsychological development and obstetric complications.
    • AntiTPOAb in early pregnancy can predict PPTD.
    • Current iodine intake recommendations may not be consistently met.

    Conclusions:

    • Screening for thyroid dysfunction in pregnancy is warranted.
    • Optimizing iodine nutrition, managing known thyroid disease, and identifying at-risk women are key strategies.
    • Levothyroxine treatment for hypothyroidism and antiTPOAb measurement for PPTD are important interventions.